Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
IRIDEX Corporation

IRIDEX Corporation (IRIX) Stock Overview

Explore IRIDEX Corporation’s financial performance, market position, analyst ratings, and future outlook.

IRIX●NASDAQ
HealthcareMedical - Devices
$0.68
$0.005(0.72%)
U.S. Market opens in 4h 45m

IRIDEX Corporation (IRIX)

Meyka AI Score

Z

Key Financials

Market Cap11.7M
P/E Ratio-3.34
EPS (TTM)$-0.20
ROE-0.79%
Fundamental Analysis

AI Price Forecasts

1 Month$0.37
3 Months$0.75
1 Year Target$1.07

IRIX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of IRIDEX Corporation (NASDAQ: IRIX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, IRIDEX Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of IRIX on the NASDAQ shows an RSI of 27.74, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $1.07 for the NASDAQ listing.

Key metrics behind IRIDEX Corporation's NASDAQ-traded stock include a P/E ratio of -3.34 and a market capitalization of 11.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of IRIX on the NASDAQ.

Price Performance (NASDAQ: IRIX)

1-Day Change
-0.72%
5-Day Change
-3.56%
1-Month Change
-19.81%
3-Month Change
-40.26%
6-Month Change
-49.62%
Year-to-Date (YTD) Change
-40.78%
1-Year Change
-48.86%
3-Year Change
-63.90%
5-Year Change
-90.70%
All-Time (Max) Change
-93.41%

Contact Information

https://www.iridex.com
650 940 4700
1212 Terra Bella Avenue, Mountain View, CA, 94043

Company Facts

930 Employees
IPO DateFeb 16, 1996
CountryUS
Actively Trading

Frequently Asked Questions